Announced Fri, 2 Jan · 11:14 IST

Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Board outcome of Board meeting held on January 02, 2026.

Listed Co AcquisitionStrategic Transactions View source PDF

GKSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Gujarat Kidney and Super Speciality Limited has approved the acquisition of a 100% equity stake in Parekhs Hospital Private Limited, an Ahmedabad-based medical and healthcare service provider, making it a wholly owned subsidiary. The deal is a cash transaction valued at Rs. 77 crore, for all 2,55,000 equity shares of the target company. Parekhs Hospital had a turnover of approximately Rs. 25.67 crore in FY2024-25, with stable revenues of around Rs. 24-26 crore over the last three financial years. The acquisition is not a related party transaction and is expected to be completed in about 2 months. The move is aimed at strengthening the company's presence in the healthcare sector and diversifying its business portfolio.

Likely market impact

This acquisition will expand Gujarat Kidney's healthcare footprint and add a new wholly owned subsidiary, though the Rs. 77 crore cash outflow is a sizable commitment. Shareholders should watch for completion timelines and integration updates.